00-f5 Title and Logo 00-f6
 guide Contents
 siteinfo Site Info


 Chapter  1
 Chapter  2
 Chapter  3
 Chapter  4
 Chapter  5
 Chapter  6
 Chapter  7
 Chapter  8
 Chapter  9
 Chapter 10
 Chapter 11
 Chapter 12
 Chapter 13
 Chapter 14
 Chapter 15
 Chapter 16
 Chapter 17
 Chapter 18
 Chapter 19
 Chapter 20
 Chapter 21



Chapter 5

Brady TJ, Wismer GL, Buxton R, Stark DD, Rosen BR. Magnetic resonance chemical shift imaging. Magn Reson Ann 1986; 55-79.

Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in-vivo. Magn Reson Med 1988; 9: 79-93.

Gadian DG. Proton NMR studies of brain metabolism. Phil Trans R Soc Lond A 1990; 333: 561-570.

Hugg JW, Matson GB, Twieg DB, Maudsley AA, Sappey-Marinier D, Weiner MW. Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn Reson Imag 1992; 10: 227-243.

Kimmich R, Hoepfel D. Volume selective multipulse spin-echo spectroscopy. J Magn Reson 1987; 72: 379-387.

Kohler SJ, Perry SB, Stewart LC, Atkinson DE, Clarke K, Ingwall JS. Analysis of 23Na NMR spectra from isolated perfused hearts. Magn Reson Med 1991; 18: 15-27.

Matson GB, Weiner MW. Chapter 15: Spectroscopy. In: Stark DD, Bradley WG (eds.). Magnetic resonance imaging. 3rd edition. Vol. 1. St. Louis (USA): Mosby Year Book Inc 1999. 181-214.

Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991; 4: 47-52.

Öz G, Alger JR, Barker PB, et mult al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014; 270: 658-679.

Ordidge RJ, Connelly A, Lohman JAB. Image selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson 1986; 66: 283-294.

Pouremad R, Wyrwicz AM. Cerebral metabolism of fluoro-desoxyglucose measured with 19F NMR spectroscopy. NMR Biomed 1991; 4: 161-166.

Rashid SA, Adam WR, Craik DJ, Shehan BP, Wellard RM. Factors affecting 39K NMR detectability in rat tissue. Magn Reson Med 1991; 17: 213-224.

Rubaek Danielsen E, Ross B. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York: Marcel Dekker 1999.

Sauter R, Schneider M, Wicklow K, Kolem H. Current status of clinically relevant techniques in magnetic resonance spectroscopy. Electromedica 1992; 60: 32-54.

Shulman GI, Rothman DL, Shulman RG. 13C NMR studies of glucose disposal in normal and non-insulin-dependent diabetic humans. Phil Trans R Soc Lond A 1990; 333: 525-529.

Southon TE, Gribbestad IS, Nilsen G, Nordlid K, Svarliaunet AJ, Unsgaard G, Rinck PA. 31P magnetic resonance spectroscopy in the follow-up of therapy of patients with astrocytomas. Radiol Diagn 1993; 34: 11-18.

Timm G, Rinck PA, Southon TE, Aasly J, Michler RP. 31P nuclear magnetic resonance spectroscopy in patients with fibromyalgia versus normals and patients with different muscular diseases. Quarterly Magn Res in Biol and Med 1996; 3: 89-92.

spaceholder 600 spaceholder 600